how long has semaglutide been used for weight loss FDA Approves Oral Semaglutide: First GLP-1 Pill Ozempic Injection For Medical Weight

Think of your stomach like a slow-draining sink

Research news Danish register study presented at the European Congress on Obesity has associated glucagon-like peptide-1 receptor agonist treatment with a 26 per cent reduction in asthma exacerbations and lower use of reliever medication among adults with asthma and overweight, obesity or type 2 diabetes Novel research has linked the use of glucagon-like peptide-1 (GLP-1) receptor agonist drugs in people with asthma to a reduction in asthma exacerbations and a fall in the use of reliever inhalers

N Engl J Med (2004) 351(13):1296305

Stephenie S, Chang YP, Gnanasekaran A, Esa NM, Gnanaraj C